APO RESEARCH · REPORT
Immobilized Trypsin
Immobilized Trypsin provides a fast and convenient method for digesting a range of concentrations of purified protein or complex protein mixtures. Digested peptides are easily separated from the Immobilized Trypsin as they flow through the spin column into the collection tube. Immobilized Trypsin is easily removed from the peptide solution because the trypsin does not pass though the column frit. Trypsin is a proteolytic enzyme, which cleaves at the carboxyl side of positively charged Lysine (Lys) and Arginine (Arg). When these amino acids are followed by the nonpolar Proline (Pro), the digestion of the site is not efficient. When Lys and Arg are followed by acids [Aspartic Acid (Asp) and Glutamic Acid (Glu)] the digestion is also not as efficient.
Product & engineering
Understand the product.
Immobilized Trypsin provides a fast and convenient method for digesting a range of concentrations of purified protein or complex protein mixtures. Digested peptides are easily separated from the Immobilized Trypsin as they flow through the spin column into the collection tube. Immobilized Trypsin is easily removed from the peptide solution because the trypsin does not pass though the column frit. Trypsin is a proteolytic enzyme, which cleaves at the carboxyl side of positively charged Lysine (Lys) and Arginine (Arg). When these amino acids are followed by the nonpolar Proline (Pro), the digestion of the site is not efficient. When Lys and Arg are followed by acids [Aspartic Acid (Asp) and Glutamic Acid (Glu)] the digestion is also not as efficient.
Selected research
Industry Research
Immobilized Trypsin Industry Research Report 2026
Market perspective
Immobilized Trypsin provides a fast and convenient method for digesting a range of concentrations of purified protein or complex protein mixtures. Digested peptides are easily separated from the Immobilized Trypsin as they flow through the spin column into the collection tube. Immobilized Trypsin is easily removed from the peptide solution because the trypsin does not pass though the column frit. Trypsin is a proteolytic enzyme, which cleaves at the carboxyl side of positively charged Lysine (Lys) and Arginine (Arg). When these amino acids are followed by the nonpolar Proline (Pro), the digestion of the site is not efficient. When Lys and Arg are followed by acids [Aspartic Acid (Asp) and Glutamic Acid (Glu)] the digestion is also not as efficient.
North American is the largest consumption place, with a consumption market share nearly 45% in 2019. Following North American, Europe is the second with the market share of 28.39%.
Market competition is intense. Promega, Thermo Scientific, G-Biosciences, SignalChem and Takara, etc. are the leaders of the industry, and they hold key patents, with high-end customers. Top 5 occupied 3/5 of the market in 2019.
Read the full market overview
According to the form, the classification of Immobilized Trypsin includes 2 ml, 4ml, etc. In addition, the proportion of 2 ml in 2019 is about 70.63%.
Immobilized Trypsin is widely used for Academic & Research Institutes and Pharmaceutical Companies. The most proportion of Immobilized Trypsin is used for Academic & Research Institutes, and the proportion in 2019 is about 62.15%.
Report Scope
This report quantifies the global Immobilized Trypsin market in terms of revenue (US$ million) and, where applicable, sales volume (K Unit), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Unit) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immobilized Trypsin Market by Company
Promega
Thermo Scientific
G-Biosciences
SignalChem
Takara
GoldBio
Creative Enzymes
ProteoChem
Immobilized Trypsin Segment by Type
2 ml
4 ml
Others
Immobilized Trypsin Segment by Application
Academic & Research Institutes
Pharmaceutical Companies
Immobilized Trypsin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immobilized Trypsin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immobilized Trypsin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immobilized Trypsin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Immobilized Trypsin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Immobilized Trypsin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Immobilized Trypsin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2 ml
- 4 ml
- Others
Applications
- Academic & Research Institutes
- Pharmaceutical Companies
Companies covered
- Promega
- Thermo Scientific
- G-Biosciences
- SignalChem
- Takara
- GoldBio
- Creative Enzymes
- ProteoChem
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Immobilized Trypsin Market Size (2021-2032)
- 2.2.2 Global Immobilized Trypsin Sales (2021-2032)
- 2.2.3 Global Immobilized Trypsin Market Average Price (2021-2032)
- 2.3 Immobilized Trypsin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 2 ml
- 2.3.3 4 ml
- 2.3.4 Others
- 2.4 Immobilized Trypsin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Academic & Research Institutes
- 2.4.3 Pharmaceutical Companies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Immobilized Trypsin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Immobilized Trypsin Sales (K Unit) of Manufacturers (2021-2026)
- 3.3 Global Immobilized Trypsin Revenue of Manufacturers (2021-2026)
- 3.4 Global Immobilized Trypsin Average Price by Manufacturers (2021-2026)
- 3.5 Global Immobilized Trypsin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Immobilized Trypsin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Immobilized Trypsin, Product Type & Application
- 3.8 Global Manufacturers of Immobilized Trypsin, Established Date
- 3.9 Global Immobilized Trypsin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Promega
- 4.1.1 Promega Company Information
- 4.1.2 Promega Business Overview
- 4.1.3 Promega Immobilized Trypsin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Promega Immobilized Trypsin Product Portfolio
- 4.1.5 Promega Recent Developments
- 4.2 Thermo Scientific
- 4.2.1 Thermo Scientific Company Information
- 4.2.2 Thermo Scientific Business Overview
- 4.2.3 Thermo Scientific Immobilized Trypsin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Thermo Scientific Immobilized Trypsin Product Portfolio
- 4.2.5 Thermo Scientific Recent Developments
- 4.3 G-Biosciences
- 4.3.1 G-Biosciences Company Information
- 4.3.2 G-Biosciences Business Overview
- 4.3.3 G-Biosciences Immobilized Trypsin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 G-Biosciences Immobilized Trypsin Product Portfolio
- 4.3.5 G-Biosciences Recent Developments
- 4.4 SignalChem
- 4.4.1 SignalChem Company Information
- 4.4.2 SignalChem Business Overview
- 4.4.3 SignalChem Immobilized Trypsin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 SignalChem Immobilized Trypsin Product Portfolio
- 4.4.5 SignalChem Recent Developments
- 4.5 Takara
- 4.5.1 Takara Company Information
- 4.5.2 Takara Business Overview
- 4.5.3 Takara Immobilized Trypsin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Takara Immobilized Trypsin Product Portfolio
- 4.5.5 Takara Recent Developments
- 4.6 GoldBio
- 4.6.1 GoldBio Company Information
- 4.6.2 GoldBio Business Overview
- 4.6.3 GoldBio Immobilized Trypsin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GoldBio Immobilized Trypsin Product Portfolio
- 4.6.5 GoldBio Recent Developments
- 4.7 Creative Enzymes
- 4.7.1 Creative Enzymes Company Information
- 4.7.2 Creative Enzymes Business Overview
- 4.7.3 Creative Enzymes Immobilized Trypsin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Creative Enzymes Immobilized Trypsin Product Portfolio
- 4.7.5 Creative Enzymes Recent Developments
- 4.8 ProteoChem
- 4.8.1 ProteoChem Company Information
- 4.8.2 ProteoChem Business Overview
- 4.8.3 ProteoChem Immobilized Trypsin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 ProteoChem Immobilized Trypsin Product Portfolio
- 4.8.5 ProteoChem Recent Developments
5 Global Immobilized Trypsin Market Scenario by Region
- 5.1 Global Immobilized Trypsin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Immobilized Trypsin Sales by Region: 2021-2032
- 5.2.1 Global Immobilized Trypsin Sales by Region: 2021-2026
- 5.2.2 Global Immobilized Trypsin Sales by Region: 2027-2032
- 5.3 Global Immobilized Trypsin Revenue by Region: 2021-2032
- 5.3.1 Global Immobilized Trypsin Revenue by Region: 2021-2026
- 5.3.2 Global Immobilized Trypsin Revenue by Region: 2027-2032
- 5.4 North America Immobilized Trypsin Market Facts & Figures by Country
- 5.4.1 North America Immobilized Trypsin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Immobilized Trypsin Sales by Country (2021-2032)
- 5.4.3 North America Immobilized Trypsin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Immobilized Trypsin Market Facts & Figures by Country
- 5.5.1 Europe Immobilized Trypsin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Immobilized Trypsin Sales by Country (2021-2032)
- 5.5.3 Europe Immobilized Trypsin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Immobilized Trypsin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Immobilized Trypsin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Immobilized Trypsin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Immobilized Trypsin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Immobilized Trypsin Market Facts & Figures by Country
- 5.7.1 South America Immobilized Trypsin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Immobilized Trypsin Sales by Country (2021-2032)
- 5.7.3 South America Immobilized Trypsin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Immobilized Trypsin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Immobilized Trypsin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Immobilized Trypsin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Immobilized Trypsin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Immobilized Trypsin Sales by Type (2021-2032)
- 6.1.1 Global Immobilized Trypsin Sales by Type (2021-2032) & (K Unit)
- 6.1.2 Global Immobilized Trypsin Sales Market Share by Type (2021-2032)
- 6.2 Global Immobilized Trypsin Revenue by Type (2021-2032)
- 6.2.1 Global Immobilized Trypsin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Immobilized Trypsin Revenue Market Share by Type (2021-2032)
- 6.3 Global Immobilized Trypsin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Immobilized Trypsin Sales by Application (2021-2032)
- 7.1.1 Global Immobilized Trypsin Sales by Application (2021-2032) & (K Unit)
- 7.1.2 Global Immobilized Trypsin Sales Market Share by Application (2021-2032)
- 7.2 Global Immobilized Trypsin Revenue by Application (2021-2032)
- 7.2.1 Global Immobilized Trypsin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Immobilized Trypsin Revenue Market Share by Application (2021-2032)
- 7.3 Global Immobilized Trypsin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Immobilized Trypsin Value Chain Analysis
- 8.1.1 Immobilized Trypsin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Immobilized Trypsin Production Mode & Process
- 8.2 Immobilized Trypsin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Immobilized Trypsin Distributors
- 8.2.3 Immobilized Trypsin Customers
9 Global Immobilized Trypsin Analyzing Market Dynamics
- 9.1 Immobilized Trypsin Industry Trends
- 9.2 Immobilized Trypsin Industry Drivers
- 9.3 Immobilized Trypsin Industry Opportunities and Challenges
- 9.4 Immobilized Trypsin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst